ERT, a global data and technology company that minimizes risk and uncertainty in clinical trials, announced that Premier Research, a clinical development service provider, has selected ERT’s Trial Oversight suite as its trial management solution.
Clinical trials are becoming increasingly complex, due in part to an array of circumstances including the use of multiple data capture modalities and the need to evaluate more study endpoints than ever before. Additionally, global trials continue to be managed by a growing number of stakeholders, which heightens risks and uncertainties. Sponsors and CROs that leverage trial management solutions can simplify the complexities, prevent trial delays and improve operational efficiencies to accelerate the clinical development process.
Through ERT’s clinical trial management, Premier Research is improving day-to-day operational workflows across study teams. Powered by ERT’s Expert technology platform, Premier Research can deliver real-time access to data analytics, key performance metrics and milestone tracking. It also delivers ease of ‘electronic Monitoring Visit Reports’ (eMVR), so customers can effectively oversee their trials and work together with Premier to identify and mitigate risks.
“ERT has developed an automated approach to study workflows and data aggregation that minimizes data duplication and human error, providing greater visibility and granularity to our study teams and customers,” said Simon Britton COO, Premier Research. “Our customers are some of the top innovators in biotech and specialty pharma, and this solution will facilitate their development of life-changing treatments and help make them available to patients more quickly.”
James Corrigan, president and CEO of ERT, said the company applauds Premier’s commitment to eliminate reactive, manual processes and transition to a more efficient and collaborative approach.
Premier Research operates in 84 countries and employs 1,000 professionals, including an international network of clinical monitors and project managers, regulatory, data management, statistical, scientific, and medical experts focused on smart study design for advanced medicines.
(Source: ERT)
